Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-018021

Chief Medical Officer sold 3,350 shares at $11.43 ($38,291)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BALDO LANCE Chief Medical Officer 2022-03-08 Sale −3,350 $11.43 $38,291 17,171 D: show line 1 in the form
Open-market sales · 3,350 sh · avg $11.43 · $38,291
Loading xslF345X03/doc4.xml…